Erik Hartwick
Concepts (66)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
3' Untranslated Regions | 1 | 2018 | 129 | 0.600 |
Why?
| RNA, Ribosomal | 1 | 2018 | 157 | 0.590 |
Why?
| Ribosomal Proteins | 1 | 2017 | 70 | 0.540 |
Why?
| Eukaryota | 1 | 2017 | 46 | 0.530 |
Why?
| Glutaminase | 1 | 2011 | 10 | 0.380 |
Why?
| Thiadiazoles | 1 | 2011 | 21 | 0.380 |
Why?
| Sulfides | 1 | 2011 | 93 | 0.360 |
Why?
| Phosphates | 1 | 2011 | 155 | 0.360 |
Why?
| Ribosomes | 3 | 2020 | 148 | 0.330 |
Why?
| Enzyme Inhibitors | 1 | 2011 | 743 | 0.300 |
Why?
| RNA, Viral | 2 | 2020 | 565 | 0.260 |
Why?
| Kidney | 1 | 2011 | 1182 | 0.240 |
Why?
| Antineoplastic Agents | 1 | 2011 | 1875 | 0.180 |
Why?
| RNA, Transfer, Val | 1 | 2020 | 3 | 0.180 |
Why?
| Insect Viruses | 1 | 2020 | 4 | 0.180 |
Why?
| Puromycin | 1 | 2020 | 11 | 0.180 |
Why?
| Plant Viruses | 1 | 2020 | 7 | 0.180 |
Why?
| Peptide Chain Elongation, Translational | 1 | 2020 | 18 | 0.180 |
Why?
| Protein Synthesis Inhibitors | 1 | 2020 | 42 | 0.180 |
Why?
| Frameshifting, Ribosomal | 1 | 2020 | 6 | 0.170 |
Why?
| Human T-lymphotropic virus 1 | 1 | 2020 | 23 | 0.170 |
Why?
| 5' Untranslated Regions | 1 | 2018 | 51 | 0.150 |
Why?
| Open Reading Frames | 1 | 2018 | 117 | 0.150 |
Why?
| Phylogeny | 1 | 2020 | 787 | 0.140 |
Why?
| Eukaryotic Cells | 1 | 2017 | 33 | 0.140 |
Why?
| Protein Biosynthesis | 1 | 2018 | 386 | 0.140 |
Why?
| RNA, Messenger | 2 | 2020 | 2550 | 0.130 |
Why?
| Genetic Variation | 1 | 2020 | 868 | 0.130 |
Why?
| Nucleic Acid Conformation | 1 | 2018 | 670 | 0.120 |
Why?
| Chromatography, Gel | 1 | 2011 | 122 | 0.100 |
Why?
| Nucleosomes | 1 | 2013 | 122 | 0.090 |
Why?
| Isoenzymes | 1 | 2011 | 283 | 0.090 |
Why?
| Protein Multimerization | 1 | 2011 | 157 | 0.090 |
Why?
| Recombinant Proteins | 1 | 2011 | 1228 | 0.080 |
Why?
| Kinetics | 1 | 2011 | 1547 | 0.070 |
Why?
| Histones | 1 | 2013 | 529 | 0.070 |
Why?
| Escherichia coli | 1 | 2011 | 723 | 0.070 |
Why?
| Peptide Fragments | 1 | 2011 | 665 | 0.070 |
Why?
| DNA-Binding Proteins | 1 | 2013 | 1311 | 0.060 |
Why?
| Transcription Factors | 1 | 2013 | 1526 | 0.060 |
Why?
| Anticodon | 1 | 2020 | 22 | 0.040 |
Why?
| RNA, Transfer, Amino Acyl | 1 | 2020 | 8 | 0.040 |
Why?
| Molecular Mimicry | 1 | 2020 | 35 | 0.040 |
Why?
| Sequence Homology, Nucleic Acid | 1 | 2020 | 152 | 0.040 |
Why?
| Valine | 1 | 2020 | 72 | 0.040 |
Why?
| RNA Folding | 1 | 2020 | 33 | 0.040 |
Why?
| Nucleotide Motifs | 1 | 2020 | 29 | 0.040 |
Why?
| Gene Expression Regulation, Viral | 1 | 2020 | 80 | 0.040 |
Why?
| Binding Sites | 1 | 2020 | 1166 | 0.040 |
Why?
| Computational Biology | 1 | 2020 | 528 | 0.030 |
Why?
| Base Sequence | 1 | 2020 | 2114 | 0.030 |
Why?
| Models, Molecular | 1 | 2020 | 1368 | 0.030 |
Why?
| Proteins | 1 | 2020 | 906 | 0.030 |
Why?
| Cell Line, Tumor | 1 | 2020 | 2700 | 0.030 |
Why?
| Polycomb-Group Proteins | 1 | 2013 | 29 | 0.030 |
Why?
| Fluorescence Resonance Energy Transfer | 1 | 2013 | 167 | 0.020 |
Why?
| Lysine | 1 | 2013 | 241 | 0.020 |
Why?
| Magnetic Resonance Spectroscopy | 1 | 2013 | 474 | 0.020 |
Why?
| DNA Damage | 1 | 2013 | 351 | 0.020 |
Why?
| Protein Structure, Tertiary | 1 | 2013 | 796 | 0.020 |
Why?
| Peptides | 1 | 2013 | 847 | 0.020 |
Why?
| Protein Binding | 1 | 2013 | 1888 | 0.020 |
Why?
| DNA | 1 | 2013 | 1350 | 0.020 |
Why?
| Mice | 1 | 2020 | 14843 | 0.010 |
Why?
| Humans | 2 | 2013 | 114045 | 0.010 |
Why?
| Animals | 1 | 2020 | 31565 | 0.010 |
Why?
|
|
Hartwick's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|